China Medical Imaging Market Size, Share & Trends Analysis Report By Modality (X-ray, Ultrasound, Computed Tomography, Magnetic Resonance Imaging, Nuclear Medicine), By End-use (Hospitals, Diagnostic Imaging Centers), And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 1 Business Day
China Medical Imaging Market Growth & Trends
The China medical imaging market size is expected to reach USD 2.7 billion by 2030, growing at a CAGR of 6.2% during the forecast period, based on a new report by Grand View Research, Inc. The growth of the market is attributed to several factors such as the increasing prevalence of chronic diseases, technological advancements to improve the turnaround time, favorable reimbursement policies, growing government funding & initiatives, rising geriatric population, and expanding healthcare infrastructure.
The growing burden of chronic diseases & rising geriatric population in China has propelled the demand for advanced medical imaging technologies, thereby boosting the market growth. For instance, according to the report published on PubMed stating ‘Cardiovascular Health and Diseases in China 2021’, the cases of patients suffering from coronary heart disease, stroke, pulmonary heart disease, heart failure, rheumatic heart disease, congenital heart disease, atrial fibrillation, and hypertension is 13 million, 11.39 million, 5.00 million, 8.90 million, 2.50 million, 2.00 million, 4.87 million, and 245 million, respectively.
The aforementioned information is suggesting the growing prevalence of cardiovascular diseases & cancer and increasing awareness about early diagnosis are expected to contribute to lucrative growth opportunities during the forecast period. Additionally, enabling early disease detection, accurate diagnosis, and effective disease management, medical imaging plays a crucial role in improving patient outcomes and enhancing the overall quality of healthcare in the context of chronic diseases. The market also benefits from a growing awareness of the importance of early disease detection and preventive healthcare.
Manufacturers in the China medical imaging industry are also contributing to its growth by expanding their product portfolios through strategic collaborations, product launches, and mergers & acquisitions. For example, in January 2023, GE Healthcare, a leading player in the industry, announced its acquisition of Caption Health, Inc., an AI healthcare provider specializing in clinical applications for early disease diagnosis using ultrasound scans. Such partnerships and advancements demonstrate the market's commitment to innovation and its focus on providing state-of-the-art solutions for early disease detection and improved patient care.
China Medical Imaging Market Report Highlights
China Medical Imaging Market Growth & Trends
The China medical imaging market size is expected to reach USD 2.7 billion by 2030, growing at a CAGR of 6.2% during the forecast period, based on a new report by Grand View Research, Inc. The growth of the market is attributed to several factors such as the increasing prevalence of chronic diseases, technological advancements to improve the turnaround time, favorable reimbursement policies, growing government funding & initiatives, rising geriatric population, and expanding healthcare infrastructure.
The growing burden of chronic diseases & rising geriatric population in China has propelled the demand for advanced medical imaging technologies, thereby boosting the market growth. For instance, according to the report published on PubMed stating ‘Cardiovascular Health and Diseases in China 2021’, the cases of patients suffering from coronary heart disease, stroke, pulmonary heart disease, heart failure, rheumatic heart disease, congenital heart disease, atrial fibrillation, and hypertension is 13 million, 11.39 million, 5.00 million, 8.90 million, 2.50 million, 2.00 million, 4.87 million, and 245 million, respectively.
The aforementioned information is suggesting the growing prevalence of cardiovascular diseases & cancer and increasing awareness about early diagnosis are expected to contribute to lucrative growth opportunities during the forecast period. Additionally, enabling early disease detection, accurate diagnosis, and effective disease management, medical imaging plays a crucial role in improving patient outcomes and enhancing the overall quality of healthcare in the context of chronic diseases. The market also benefits from a growing awareness of the importance of early disease detection and preventive healthcare.
Manufacturers in the China medical imaging industry are also contributing to its growth by expanding their product portfolios through strategic collaborations, product launches, and mergers & acquisitions. For example, in January 2023, GE Healthcare, a leading player in the industry, announced its acquisition of Caption Health, Inc., an AI healthcare provider specializing in clinical applications for early disease diagnosis using ultrasound scans. Such partnerships and advancements demonstrate the market's commitment to innovation and its focus on providing state-of-the-art solutions for early disease detection and improved patient care.
China Medical Imaging Market Report Highlights
- Based on modality, the ultrasound segment held the largest market share of 29.06% in 2022 owing to enhanced capabilities of this type such as treating gallbladder disease and guiding a needle for biopsy or tumor treatment
- The Computed Tomography (CT) segment is expected to showcase the fastest CAGR during the forecast period
- Based on end-use, the hospital segment had the largest market share of 34.94% in 2022, owing to the rising demand for more accurate diagnostic tools
- Technological advancements are also anticipated to drive the growth of the advanced wound care market in the forthcoming years
- Some of the major market players are GE HealthCare, Siemens Healthcare GmbH, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shanghai United Imaging Healthcare Co., LTD
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End-use outlook
2.3. Competitive Insights
CHAPTER 3. CHINA MEDICAL IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing prevalence of chronic diseases
3.4.1.2. Increasing number of government initiatives
3.4.1.3. Rapid technological advancements
3.4.1.4. Increasing trends of preventive healthcare and disease screening programs
3.4.2. Market restraint analysis
3.4.2.1. High cost of devices
3.4.2.2. Increasing use of refurbished products
3.4.2.3. Shortage of trained radiologists
3.5. China Medical Imaging Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. CHINA MEDICAL IMAGING MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. X-ray
4.1.2. Ultrasound
4.1.3. Computed Tomography (CT)
4.1.4. Magnetic Resonance Imaging (MRI)
4.1.5. Nuclear Imaging
4.2. Modality Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global China Medical Imaging Market by Modality Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. X-ray
4.5.1.1. X-ray market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Ultrasound
4.5.2.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.1. 2D market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.2. 3D/4D market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.3. Doppler market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Computed Tomography (CT)
4.5.3.1. Computed tomography (CT) market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.1. High slice market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.2. Mid slice market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.3. Low slice market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.4. Cone Beam market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Magnetic Resonance Imaging (MRI)
4.5.4.1. Magnetic resonance imaging (MRI) market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.1.1. Low - strength market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.1.2. Mid - strength market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.1.3. High - strength market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Nuclear Imaging
4.5.5.1. Nuclear imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.5.1.1. SPECT market estimates and forecast 2018 to 2030 (USD Million)
4.5.5.1.2. PET market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. CHINA MEDICAL IMAGING MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic Imaging Centers
5.1.3. Others
5.2. Product Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global China Medical Imaging Market by Product Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Diagnostic Imaging Centers
5.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.4. List of key distributors and channel partners
6.5. Key customers
6.6. Key company market share analysis, 2022
6.7. Key companies profiled
6.7.1. GE HealthCare
6.7.1.1. Company overview
6.7.1.2. Financial performance
6.7.1.3. Product benchmarking
6.7.1.4. Strategic initiatives
6.7.2. Siemens Healthcare GmbH
6.7.2.1. Company overview
6.7.2.2. Financial performance
6.7.2.3. Product benchmarking
6.7.2.4. Strategic initiatives
6.7.3. Koninklijke Philips N.V.
6.7.3.1. Company overview
6.7.3.2. Financial performance
6.7.3.3. Product benchmarking
6.7.3.4. Strategic initiatives
6.7.4. Canon Medical Systems Corporation
6.7.4.1. Company overview
6.7.4.2. Financial performance
6.7.4.3. Product benchmarking
6.7.4.4. Strategic initiatives
6.7.5. Shenzhen Mindray Bio - Medical Electronics Co., Ltd.
6.7.5.1. Company overview
6.7.5.2. Financial performance
6.7.5.3. Product benchmarking
6.7.5.4. Strategic initiatives
6.7.6. Shanghai United Imaging Healthcare Co., LTD
6.7.6.1. Company overview
6.7.6.2. Financial performance
6.7.6.3. Product benchmarking
6.7.6.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End-use outlook
2.3. Competitive Insights
CHAPTER 3. CHINA MEDICAL IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing prevalence of chronic diseases
3.4.1.2. Increasing number of government initiatives
3.4.1.3. Rapid technological advancements
3.4.1.4. Increasing trends of preventive healthcare and disease screening programs
3.4.2. Market restraint analysis
3.4.2.1. High cost of devices
3.4.2.2. Increasing use of refurbished products
3.4.2.3. Shortage of trained radiologists
3.5. China Medical Imaging Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. CHINA MEDICAL IMAGING MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. X-ray
4.1.2. Ultrasound
4.1.3. Computed Tomography (CT)
4.1.4. Magnetic Resonance Imaging (MRI)
4.1.5. Nuclear Imaging
4.2. Modality Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global China Medical Imaging Market by Modality Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. X-ray
4.5.1.1. X-ray market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Ultrasound
4.5.2.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.1. 2D market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.2. 3D/4D market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.3. Doppler market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Computed Tomography (CT)
4.5.3.1. Computed tomography (CT) market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.1. High slice market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.2. Mid slice market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.3. Low slice market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.1.4. Cone Beam market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Magnetic Resonance Imaging (MRI)
4.5.4.1. Magnetic resonance imaging (MRI) market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.1.1. Low - strength market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.1.2. Mid - strength market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.1.3. High - strength market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Nuclear Imaging
4.5.5.1. Nuclear imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.5.1.1. SPECT market estimates and forecast 2018 to 2030 (USD Million)
4.5.5.1.2. PET market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. CHINA MEDICAL IMAGING MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic Imaging Centers
5.1.3. Others
5.2. Product Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global China Medical Imaging Market by Product Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Diagnostic Imaging Centers
5.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.4. List of key distributors and channel partners
6.5. Key customers
6.6. Key company market share analysis, 2022
6.7. Key companies profiled
6.7.1. GE HealthCare
6.7.1.1. Company overview
6.7.1.2. Financial performance
6.7.1.3. Product benchmarking
6.7.1.4. Strategic initiatives
6.7.2. Siemens Healthcare GmbH
6.7.2.1. Company overview
6.7.2.2. Financial performance
6.7.2.3. Product benchmarking
6.7.2.4. Strategic initiatives
6.7.3. Koninklijke Philips N.V.
6.7.3.1. Company overview
6.7.3.2. Financial performance
6.7.3.3. Product benchmarking
6.7.3.4. Strategic initiatives
6.7.4. Canon Medical Systems Corporation
6.7.4.1. Company overview
6.7.4.2. Financial performance
6.7.4.3. Product benchmarking
6.7.4.4. Strategic initiatives
6.7.5. Shenzhen Mindray Bio - Medical Electronics Co., Ltd.
6.7.5.1. Company overview
6.7.5.2. Financial performance
6.7.5.3. Product benchmarking
6.7.5.4. Strategic initiatives
6.7.6. Shanghai United Imaging Healthcare Co., LTD
6.7.6.1. Company overview
6.7.6.2. Financial performance
6.7.6.3. Product benchmarking
6.7.6.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 China medical imaging market, by modality, 2018 - 2030 (USD Million)
Table 3 China medical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 China medical imaging market, by modality, 2018 - 2030 (USD Million)
Table 3 China medical imaging market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 China medical imaging market segmentation
Fig. 8 Market summary, 2022
Fig. 9 Market lineage outlook
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Reimbursement pathway
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 15 Porter’s five forces analysis
Fig. 16 China medical imaging market: Modality movement analysis
Fig. 17 China medical imaging market: Modality scope & market share
Fig. 18 China medical imaging market modality outlook: Key takeaways
Fig. 19 X-ray market, 2018 - 2030 (USD Million)
Fig. 20 Ultrasound market, 2018 - 2030 (USD Million)
Fig. 21 Computed Tomography (CT) market, 2018 - 2030 (USD Million)
Fig. 22 Magnetic Resonance Imaging (MRI) market, 2018 - 2030 (USD Million)
Fig. 23 Nuclear Medicine market, 2018 - 2030 (USD Million)
Fig. 24 China medical imaging market: End-use movement analysis
Fig. 25 China medical imaging market: End-use scope & market share
Fig. 26 China medical imaging market end-use outlook: Key takeaways
Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
Fig. 28 Diagnostic Imaging Centres market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Strategy framework
Fig. 31 Company share analysis, 2022 Report
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 China medical imaging market segmentation
Fig. 8 Market summary, 2022
Fig. 9 Market lineage outlook
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Reimbursement pathway
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 15 Porter’s five forces analysis
Fig. 16 China medical imaging market: Modality movement analysis
Fig. 17 China medical imaging market: Modality scope & market share
Fig. 18 China medical imaging market modality outlook: Key takeaways
Fig. 19 X-ray market, 2018 - 2030 (USD Million)
Fig. 20 Ultrasound market, 2018 - 2030 (USD Million)
Fig. 21 Computed Tomography (CT) market, 2018 - 2030 (USD Million)
Fig. 22 Magnetic Resonance Imaging (MRI) market, 2018 - 2030 (USD Million)
Fig. 23 Nuclear Medicine market, 2018 - 2030 (USD Million)
Fig. 24 China medical imaging market: End-use movement analysis
Fig. 25 China medical imaging market: End-use scope & market share
Fig. 26 China medical imaging market end-use outlook: Key takeaways
Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
Fig. 28 Diagnostic Imaging Centres market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Strategy framework
Fig. 31 Company share analysis, 2022 Report
